# ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

> clinical trial · VERIFIED · 2026-06-25

Status: RECRUITING · Sponsor: BioNTech SE · Condition: Breast Neoplasms

- Company: BioNTech SE
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07173751

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.